SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies informs about clarification on movement in volume

20 Nov 2025 Evaluate
With reference to email ref no. L/SURV/ONL/PV/AA/ 2025-2026 / 689 dated 20.11.2025 with regard to increase in volume of securities of Venus Remedies, Venus Remedies has informed that the company has made all the necessary disclosures in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 from time to time and has not withheld any material information that in its opinion would have a bearing on the price / volume behaviour in the company's script. The said significant increase in the volume of security is likely because of positive quarterly results and is purely market driven.

The above information is a part of company’s filings submitted to BSE.

Venus Remedies Share Price

1039.95 45.80 (4.61%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×